N/A
Manufactured by Upsher-Smith Laboratories, LLC
29,334 FDA adverse event reports analyzed
Last updated: 2026-04-14
AMIODARONE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Upsher-Smith Laboratories, LLC. The most commonly reported adverse reactions for AMIODARONE HYDROCHLORIDE include DYSPNOEA, ASTHENIA, FATIGUE, OFF LABEL USE, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AMIODARONE HYDROCHLORIDE.
Out of 10,677 classified reports for AMIODARONE HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 29,334 FDA FAERS reports that mention AMIODARONE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DYSPNOEA, ASTHENIA, FATIGUE, OFF LABEL USE, DRUG INEFFECTIVE, PRODUCT USE IN UNAPPROVED INDICATION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Upsher-Smith Laboratories, LLC in connection with AMIODARONE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.